Germany Emerges as Europe's Cannabis Import Hub With 201 Tonnes in 2025
Germany imported over 201 tonnes of medical cannabis in 2025, cementing its position as Europe's largest market and creating opportunities for global suppliers.
Germany has established itself as Europe's dominant medical cannabis market, importing more than 201 tonnes of cannabis products during the 2025 calendar year. This massive import volume positions the country as the primary gateway for international cannabis companies seeking European market access, fundamentally reshaping the global cannabis trade landscape.
The import surge reflects Germany's mature regulatory framework and robust patient demand, which has created the most liquid medical cannabis market in Europe. Unlike neighboring countries with restrictive programs, Germany's streamlined import processes and established distribution networks attract suppliers from Canada, the Netherlands, and other established production hubs. This regulatory advantage translates into sustained revenue opportunities for cultivation companies with European export capabilities.
Germany's import dominance creates a ripple effect across the European cannabis sector, as other EU countries observe the economic benefits of liberalized medical cannabis policies. The country's success in managing large-scale cannabis imports provides a regulatory blueprint that could accelerate market development across the continent. European cannabis companies are positioning themselves to capitalize on this expansion, with many establishing German subsidiaries to access the lucrative import market.
The 201-tonne import figure represents substantial market value, with medical cannabis typically commanding premium pricing in European markets. This volume indicates Germany's medical cannabis market has achieved the scale necessary to attract institutional investment and support larger cultivation operations. The consistent import demand also provides revenue visibility for international suppliers, making German market access a key factor in cannabis company valuations.
Germany's cannabis market evolution extends beyond medical applications, as recent adult-use legalization measures create additional growth vectors. The established medical infrastructure and import expertise position Germany to lead European cannabis market development over the next decade. International cannabis companies without German market access face increasing competitive disadvantage as the country solidifies its role as Europe's cannabis hub.